Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

Clinical trial NCT02343835 · COMPLETED

Trial details

NCT number: NCT02343835
Sponsor: Fuda Cancer Hospital, Guangzhou
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2015-01-01
Primary completion: 2020-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.